SCHEMBL7016544

SCHEMBL7016544

Cc1ccccc1-c1cc(-n2cnc3cc(-c4ccnc(N)n4)ccc32)nc(N[C@@H](C)c2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LCK P06239 12/20 0.61
PFKFB3 Q16875 1/20 0.39
PDE4A P27815 1/20 0.38
PDE4D Q08499 1/20 0.38
PLK1 P53350 2/20 0.38
CYP3A4 P08684 1/20 0.38
PLK3 Q9H4B4 1/20 0.38
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
HPGD P15428 1/20 0.35
MKNK1 Q9BUB5 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015846 0.91 LCK (0.58) LCKPFKFB3PLK1CYP3A4PLK3
SCHEMBL7575747 0.89 LCK (0.76) LCKPLK1CYP3A4PLK3ALDH1A1
SCHEMBL7016254 0.89 LCK (0.76) LCKPLK1CYP3A4PLK3ALDH1A1
SCHEMBL7018434 0.88 LCK (0.76) LCKPFKFB3PLK1CYP3A4PLK3
SCHEMBL7023575 0.86 LCK (0.71) LCKPFKFB3PDE4APDE4DALDH1A1
SCHEMBL7024612 0.84 LCK (0.70) LCKPLK1CYP3A4PLK3ALDH1A1
SCHEMBL7496875 0.84 LCK (0.46) LCKPDE4APDE4DPLK1CYP3A4
SCHEMBL7018502 0.80 LCK (0.58) LCKPLK1CYP3A4PLK3ALDH1A1
SCHEMBL7020588 0.79 LCK (0.71) LCKPLK1CYP3A4PLK3ALDH1A1
SCHEMBL7568847 0.79 LCK (0.71) LCKPLK1CYP3A4PLK3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP claimed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US claimed
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed